tm logo
PILLIE
Dead/Cancelled
CANCELLED - SECTION 8

section 8

on 05 Jun 2020

Last Applicant/ Owned by

301 ¿ E. Main St. Ste# 105

Norman

OK

73069

Serial Number

85639079 filed on 30th May 2012

Registration Number

4394743 registered on 03rd Sep 2013

in the Principal Register

Correspondent Address

NEHA JAISWAL

LAW OFFICE OF NEHA JAISWAL

405 ENCLAVE CIR APT 209

COSTA MESA, CA 92626-8121

Filing Basis

1. use application currently

Disclaimer

NO DATA

PILLIE

The mark consists of a sub-human character in a shape of a pill with arms folded across the chest and the left leg is extended outwards. The letters "Pillie" are imprinted on the right shoe. The character has a big smile on its face, and is wearing pants and shoes. Color is not claimed as a feature of the mark. Dietary and nutritional supplements; Dietary and nutritional supplements containingRead More

Classification Information


Class [005]
Pharmaceutical Products


Dietary and nutritional supplements; Dietary and nutritional supplements containing a vitamin, a mineral, an herb or other botanical extract; an amino acid for nutritional purposes; dietary concentrate, metabolite, constituent or extract for use by man to supplement the diet by increasing the total dietary intake; Dietary supplements for human consumption; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Herbal supplements; Natural herbal supplements; Nutraceuticals for use as a dietary supplement for Gastrointestinal, Digestive and liver support; Vitamin and mineral supplements for respiratory system support; dietary supplements for Mood, sleep, memory support; dietary supplements for Central and peripheral nervous system support; dietary supplements for Vision support, Hearing support, Cardiovascular support, Metabolic support; dietary supplements for Bone, joint and muscle support; dietary supplements for Dermatologic support and Anti-aging support; nutritional supplements for Beauty, namely, hair, skin, nails support; dietary supplements for Hormone and endocrine support, Weight management/support, Blood sugar support, Energy support, Immune support, Respiratory support, Men's health and Women's health; dietary supplements for Exercise and physical performance support; dietary supplements for Infant, toddler, children nutritional support; dietary supplements for Geriatric health and support; dietary supplements for Urinary support; Natural Product Extracts in the nature of plant extracts for medical purposes; dietary supplements for Anti-inflammatory support; dietary supplements for Lipid support and Anti-oxidant support; dietary and nutritional supplements containing Greens, Fibers, Fruits, Vegetables, and superfoods; dietary Fibers for treating constipation; fruit-based Meal replacement bars for medical purposes; Amino Acids for nutritional purposes; Nutritional supplements, namely, carbohydrates in powdered form; Protein and peptide formulas for use as dietary and nutritional supplements; Prebiotics/Probiotics; Nutritional supplements in the form of solid dosage forms, semi-solid dosage forms, liquid dosage forms and parenteral dosage forms; Pharmaceutical preparations for Alzheimer's Dementia treatment; pharmaceutical preparations in the nature of Amoebicides/Antiprotozoals; Anabolic/Androgenic Steroids; Analeptic drugs; Analgesics/Anti-pyretics; Anesthetic Agent for surgical and non-surgical use; Antacids/Antiflatulents; pharmaceutical preparations, namely, Anthelmintics; Anti-Arthritis preparations; Anti-Inflammatory Drugs; Anti-Tuberculosis Drugs; Anti-acne/Anti-psoriatic Drugs; Anti-allergic Drugs; Antibiotics/Antibacterials; Anticancer Drugs; Anti-coagulant and Antithrombotic Agents; pharmaceutical preparations, namely, Anti-convulsants; pharmaceutical preparations, namely, Anti-depressants; Anti-diabetic drugs; Antidiarrheals; pharmaceutical preparations in the nature of Anti-emetics; Anti-epileptic pharmaceutical preparations; Anti-fungal preparations; Antiinfectives; Anti-malarials; Anti-migraine Drugs; Antiobesity Drugs; Anti-osteoporotic Agents; Anti-Parkinson's drugs; Anti-psychotic drugs; Anti-retroviral drugs; Anti-spasmodics drugs; Antitussive drugs; pharmaceutical preparations, namely, Anti-ulcerants; Antivirals; Anxiolytics/Sedatives; Appetite Stimulants; Benign Prostatic Hyperplasia Drugs; Biologics and Biosimilars for the treatment of respiratory diseases; pharmaceuticals in the nature of Birth Control preparations; pharmaceuticals in the nature of Cardiovascular Agents; Cognitive and ADHD drugs; pharmaceutical preparations in the nature of cholesterol and Hypolipedemic Agents; pharmaceutical preparations for Cough and Cold treatment; Diuretics; Electrolyte Solutions for the treatment of respiratory diseases, namely, cough, cold, and asthma; pharmaceuticals for Erectile Dysfunction Therapy; Expectorants/Cold Preparations/Mucolytes; pharmaceuticals in the nature of Eye and Ear Preparations; pharmaceuticals for the treatment of Gastroenterology issues; pharmaceuticals in the nature of Glucose solutions for the treatment of respiratory diseases; pharmaceuticals, namely, Gout Preparations; pharmaceuticals, namely, Haematinic Preparation; pharmaceuticals, namely, Haemorrhoelogic Agents; pharmaceuticals, namely, Haemostatics; pharmaceutical preparations for Hormone Treatment; pharmaceuticals, namely, Hormone Replacement Therapy; pharmaceutical preparations for Inflammation and Immunology; pharmaceuticals, namely, Immunosuppressants; Inhaler drugs for the treatment of respiratory diseases; Intranasal agents for the treatment of respiratory diseases; Intravenous drugs for the treatment of respiratory diseases; Iron Chelators; pharmaceuticals for the treatment of Irritable Bowel Syndrome; Nasal Preparations for the treatment of respiratory diseases; pharmaceutical preparations in the nature of Non-steroidal anti-inflammatory agents for the treatment of respiratory disease; OTC drugs for the treatment of respiratory diseases; Otic drugs for the treatment of respiratory diseases; Ophthalmologic drugs and preparations; pharmaceutical preparations for Pain Treatment; pharmaceutical preparations for Palliative Treatment; Poison antidotes; Psychiatric and psychotropic drugs; Respiratory Drugs, namely, pharmaceutical products for treating respiratory diseases; Saline Solutions for medical purposes; Sedative/Hypnotics; Small Molecule drugs for the treatment of respiratory diseases; Skeletal Muscle Relaxant; pharmaceutical preparations for the treatment of Sexually transmitted diseases; Suppository drugs; Systemic Corticosteroids; Topical Anti- Infectives; Topical Corticosteroids; Topical Preparations for the treatment of respiratory diseases; pharmaceutical preparations in the nature of Urinary Smooth Muscle Contractor; Urinary Smooth Muscle Relaxants; Uterine Stimulants; Vaccines; Vertigo Treatments; Vitamins and Mineral drugs, solutions and preparations; Wart Treatments


First Use Date in General

29th May 2012

First Use Date in Commerce

29th May 2012

Mark Details


Serial Number

No 85639079

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

02.11.16 -

Smiley faces

04.01.25 -

Other supernatural, fictional or legendary characters

Description of Design Search

The mark consists of a sub-human character in a shape of a pill with arms folded across the chest and the left leg is extended outwards. The letters "Pillie" are imprinted on the right shoe. The character has a big smile on its face, and is wearing pants and shoes.

Legal History


Show more

Status DateAction Taken
05th Jun 2020CANCELLED SEC. 8 (6-YR)
03rd Sep 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03rd Sep 2013REGISTERED-PRINCIPAL REGISTER
18th Jun 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18th Jun 2013PUBLISHED FOR OPPOSITION
29th May 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13th May 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
06th May 2013APPROVED FOR PUB - PRINCIPAL REGISTER
02th Apr 2013TEAS/EMAIL CORRESPONDENCE ENTERED
02th Apr 2013CORRESPONDENCE RECEIVED IN LAW OFFICE